Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

PERQ1 Inhibitors

The chemical class of PERQ1 Inhibitors encompasses a range of compounds designed to target and modulate the activity of PERQ1, a protein integral to the cellular machinery involved in signal transduction and the regulation of insulin signaling pathways. This class is marked by a strategic approach to influence the functions of PERQ1, aiming to manipulate its role in crucial cellular processes. The development of these inhibitors represents a sophisticated understanding of PERQ1's interactions, particularly its binding with GRB10 and involvement in various signaling pathways. By focusing on these interactions and pathways, PERQ1 inhibitors are positioned to alter the protein's activity, thereby affecting the downstream processes it regulates. PERQ1 inhibitors are developed with the intention of directly affecting the protein's ability to participate in and facilitate critical signaling mechanisms within the cell. This includes targeting the protein's involvement in the insulin signaling pathway, a vital process for regulating glucose metabolism and cellular growth responses. By modulating PERQ1's activity in this pathway, these inhibitors can influence how cells respond to insulin, with implications for the regulation of glucose levels and energy metabolism. Moreover, PERQ1's role in broader signal transduction processes makes it a significant target for these inhibitors, as they can alter the protein's influence on various cellular responses to external stimuli. This is particularly relevant in the context of growth factor receptor signaling, where PERQ1 plays a role in mediating cellular responses to growth factors.

In addition to the signal transduction pathways, PERQ1 inhibitors also focus on the protein's involvement in mRNA regulation. By targeting the mechanisms through which PERQ1 influences mRNA stability and translation, these inhibitors can affect gene expression at a post-transcriptional level. This aspect of PERQ1's function is crucial for the regulation of various genes and proteins that play roles in cellular growth, metabolism, and development. The inhibitors in this class are, therefore, significant for their potential to modulate key biological processes at the molecular level. The exploration and development of PERQ1 inhibitors underscore the intricate and complex nature of cellular signaling networks. By specifically targeting PERQ1, these compounds offer insights into the protein's role within these networks and provide a means to explore the consequences of modulating its activity. The study of PERQ1 inhibitors is not just about understanding a single protein's function; it represents a broader endeavor to comprehend the dynamic interplay of signaling pathways in cellular regulation. Through their specific action on PERQ1, these inhibitors contribute to the expanding knowledge of cellular communication and regulation, highlighting the potential of targeted molecular interventions in understanding and manipulating fundamental biological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

As a PI3K inhibitor, LY294002 could possibly inhibit PERQ1 by impacting the PI3K/AKT signaling pathway.

MK-2206 dihydrochloride

1032350-13-2sc-364537
sc-364537A
5 mg
10 mg
$182.00
$332.00
67
(1)

As an Akt inhibitor, MK-2206 could possibly inhibit PERQ1 by affecting Akt signaling.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib, a PDGF receptor inhibitor, might inhibit PERQ1 by impacting PDGF receptor signaling.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib, a Src inhibitor, could possibly inhibit GIGYF1 by affecting Src family kinase PERQ1.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

Erlotinib, a tyrosine kinase inhibitor, might inhibit PERQ1 by impacting tyrosine kinase activity in growth factor signaling.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib, an EGFR inhibitor, could possibly inhibit PERQ1 by affecting EGFR signaling pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib, a proteasome inhibitor, might inhibit PERQ1 by impacting protein degradation pathways.

GSK-3 Inhibitor XVI

252917-06-9sc-221691
sc-221691A
5 mg
25 mg
$180.00
$610.00
4
(1)

GSK-3 Inhibitor XVI, a GSK3 inhibitor, could possibly inhibit PERQ1 by affecting GSK3 signaling.